公开(公告)号：US10160726B2

公开(公告)日：2018-12-25

申请号：US15500870

申请日：2015-08-03

申请人： NOVARTIS AG

发明人： Javier de Vicente Fidalgo ,  Haiying He ,  Cheng Hu ,  Zhigan Jiang ,  Xiaolin Li ,  Peichao Lu ,  Wosenu Mergo ,  Daniel Mutnick ,  Folkert Reck ,  Alexey Rivkin ,  Colin Keith Skepper ,  Xiaojing Michael Wang ,  Jianhua Xia ,  Yongjin Xu

IPC分类号： C07D215/38 ,  C07D215/22 ,  A61K31/4709 ,  A61K31/496 ,  A61K31/5377 ,  A61K31/5386 ,  A61K45/06 ,  C07D401/04 ,  C07D401/14 ,  C07D405/14 ,  C07D413/14 ,  C07D419/14 ,  C07D471/04 ,  C07D471/10 ,  C07D487/10 ,  C07D498/10

摘要： This invention is in the field of medicinal chemistry and relates to compounds, and pharmaceutical compositions thereof, that inhibit bacterial gyrase. The compounds are useful as inhibitors of bacterial gyrase activity and bacterial infections, and have the structure of Formula (I) as further described herein. The invention further provides pharmaceutical compositions comprising a compound of Formula (I) and methods of using the compounds and compositions to treat bacterial infections.